METHOD FOR EVALUATING THE DEGREE OF GESTOSIS SEVERITY

FIELD: medicine, obstetrics. ^ SUBSTANCE: starting from the 5th wk of pregnancy it is necessary to detect the content of endothelin-1 (ET) and sodium oxide metabolites (nitrites and nitrates - NOx) in blood serum. At NOx content ranged 20.9-24.8 mcM/l, and ET-1 ranged 0.7-3.9 pkg/ml one should concl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: AFONINA TAMARA ANDREEVNA, KRUKIER IRINA IVANOVNA, DRUKKER NINA ALEKSANDROVNA, POGORELOVA TAT'JANA NIKOLAEVNA, ORLOV ALEKSANDR VLADIMIROVICH
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, obstetrics. ^ SUBSTANCE: starting from the 5th wk of pregnancy it is necessary to detect the content of endothelin-1 (ET) and sodium oxide metabolites (nitrites and nitrates - NOx) in blood serum. At NOx content ranged 20.9-24.8 mcM/l, and ET-1 ranged 0.7-3.9 pkg/ml one should conclude upon the development of light-degree gestosis, and at NOx value ranged 24.8-49.6 mcM/l, and ET-1 ranged 4.0-8.3 pkg/ml one should diagnose average-degree gestosis. The innovation suggested enables to decrease pharmacological impact upon a mother and a fetus due to prescribing up-to-date adequate therapy of gestosis that corresponds to its severity degree. ^ EFFECT: higher accuracy of evaluation. ^ 3 ex, 1 tbl